Study to Determine the Safety, Tolerability, Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination With ABBV-181 in Subjects With Locally Advanced or Metastatic Solid Tumors

Condition:   Advanced Solid Tumors Cancer
Interventions:   Drug: ABBV-151;   Drug: ABBV-181
Sponsor:   AbbVie
Not yet recruiting

http://bit.ly/2t0RhCI